JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowen, H. T.
Right arrow Articles by Omaye, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowen, H. T.
Right arrow Articles by Omaye, S. T.
Journal of the American College of Nutrition, Vol. 17, No. 2, 171-179 (1998)
Published by the American College of Nutrition


Original Paper

Oxidative Changes Associated with ß-Carotene and {alpha}-Tocopherol Enrichment of Human Low-Density Lipoproteins

Hazel T. Bowen, MS and Stanley T. Omaye, PhD, FACN

Department of Nutrition, University of Nevada, Reno, Nevada

Address reprint requests to: Stanley T. Omaye, Department of Nutrition, Mail Stop 142, University of Nevada, Reno, NV 89557


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Objective: To determine what effects enrichment of human low-density lipoprotein (LDL) with combinations of {alpha}-tocopherol and ß-carotene would exert on LDL oxidation and attempt to define the nature of the effects.

Methods: Human plasma was pooled and {alpha}-tocopherol and ß-carotene was added in a four-by-four design resulting in the enrichment of LDL with {alpha}-tocopherol and ß-carotene in varying concentrations. Enriched and control LDL was oxidized in Cu2+ mediated oxidation system and resistance of LDL to oxidation was determined by lag time, thiobarbituric acid reactive substances (TBARS) activity, and rate of oxidation.

Results: Increasing LDL {alpha}-tocopherol concentration had a linear relationship with lag time and a negative correlation with rate of oxidation. LDL ß-carotene concentration was linearly correlated with the rate of LDL oxidation and ß-carotene loss, and exponentially related to TBARS concentration.

Conclusions: These results support earlier findings for the protective effect of {alpha}-tocopherol against LDL oxidation, and suggest that ß-carotene participates as a prooxidant in the oxidative degradation of LDL under these conditions. Since high levels of {alpha}-tocopherol did not mitigate the prooxidative effect of ß-carotene, these result indicate that increased LDL ß-carotene may cancel the protective qualities of {alpha}-tocopherol.

Key words: ß-carotene, {alpha}-tocopherol, low-density lipoproteins, lipid peroxidation, toxicity


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Although it has been known for some time that elevated plasma low-density lipoprotein (LDL) is strongly associated with increased risk of cardiovascular disease, the possible mechanisms by which elevated LDL mediates atherosclerosis remain unclear. A series of in vivo and in vitro studies have provided the background for the development of a current theory of atherogenesis which implicates oxidative modified LDL in atheroma formation and progression [13]. Evidence supporting in vivo oxidation of LDL is provided by a variety of biochemical, histochemical, pathologic, and immunocytological studies. For example, products of lipid peroxidation have been found associated with plasma LDL [4] and trace amounts of oxidized LDL have been found in human and animal plasma [5,6]. Plasma of humans and rabbits has been shown to contain autoantibodies against several forms of oxidized LDL [7,8], and, in certain subjects, oxidized LDL and/or peroxide levels are elevated [911]. The presence of epitopes oxidized LDL [7,8,12], as well as oxidized LDL itself [13], have been demonstrated in arterial lesions in humans and rabbits [1416].

Cardiovascular diseases resulting from oxidative damage may be prevented and/or mitigated by dietary antioxidants [17]. Thus, optimization of plasma antioxidant levels, and hence LDL content of antioxidants, may prevent atherosclerotic cardiovascular diseases. For the most part, research efforts have focused almost exclusively on the effect of single dietary antioxidants on the resistance of LDL to in vitro oxidation. Increasing awareness of the complex interactions among the enzymes, proteins, and water and fat-soluble dietary compounds that constitute the body’s antioxidant protection system have led in recent years to investigations which examine the effects that combinations of dietary antioxidants have on the susceptibility of LDL to oxidative modification [18].

The protective effect of {alpha}-tocopherol against oxidation of LDL in both cell-mediated and cell-free in vitro systems has been repeatedly confirmed [1923]. Ascorbate has been shown to be an effective water-soluble antioxidant for LDL by itself [13,24], as well as playing a synergistic role with {alpha}-tocopherol [25]. Interest in ß-carotene and other carotenoids reached a peak in the early 1990’s in response to epidemiological data indicating that a diet high in fruits and vegetables and a high plasma level of ß-carotene associated with decreased risk of cardiovascular diseases and cancer [26,27]. ß-Carotene may act additively and synergistically with {alpha}-tocopherol to protect tissues in vivo [28], perhaps, in part, by protection of ß-carotene by {alpha}-tocopherol [25,29]. ß-Carotene was reported to be 20 times more potent on a molar basis than {alpha}-tocopherol as an antioxidant for LDL in vitro [30]. Paradoxically, other reports indicate that ß-carotene has prooxidant effects which are dependent on oxygen tension [31].

The goal of the present project was to establish what effects enrichment of LDL with various combinations of {alpha}-tocopherol and ß-carotene would produce on the process of LDL oxidation and to attempt to define the nature of the effects.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Subjects
A total of 239 students, between the ages of 18 and 25 at the University of Nevada, Reno, volunteered to participate in this study which spanned 1 year. They reported themselves to be in good health, with no history of heart disease. The purpose and procedures were explained and written consent was obtained from all participants. The research proposal was approved by the Biomedical Human Subjects Review Committee of the University of Nevada, Reno.

Sample Collection and Preparation
Non-fasting blood samples were obtained by venipuncture and collected into Vacutainer brand evacuated tubes (Becton Dickinson, Rutherfood, NJ) containing 15% EDTA. All samples were collected in subdued light and immediately placed on ice in the dark. Samples were centrifuged at 1,900 xg for 20 minutes to separate the plasma fraction. Plasma from all subjects was pooled prior to enrichment experiments.

In vitro {alpha}-Tocopherol and ß-Carotene Enrichment
D, L.-{alpha}-tocopherol, Type V, 67% and ß-carotene was synthetic, all-trans, type I, ß-carotene, 97%, both purchased from Sigma Chemical Company, St Louis, MO. These synthetic forms are commonly found in a variety of vitamin or nutrient supplements. Foods contain different, but related compounds, predominantly {lambda}-tocopherol and carotenoids [32,33].

Experiment 1.
Five mg of ß-carotene was added to a 10 ml volumetric flask and the volume adjusted with dimethyl sulfoxide, purged with nitrogen, sealed tightly and wrapped in foil. The flask was placed on an Adams Nutator Mixer (Clay Adams, Div. Becton, Dickinson, and Co., Parsippany, NJ) and mixed gently for 2 hours, then allowed to stand overnight. Prior to enrichment experiments, the solution was filtered with Whatman #1 filter paper to remove undissolved ß-carotene, and the concentration of ß-carotene was determined by HPLC as described below.

Plasma was supplemented with {alpha}-tocopherol or ß-carotene according to a modification described by Esterbauer et al [13]. Pooled plasma was divided equally into 50 ml plastic centrifuge tubes. An aliquot of a solution containing 1 mg/ml {alpha}-tocopherol dissolved in dimethyl sulfoxide (DMSO) was added to reach a final concentration of 0, 30, 40 and 50 µg {alpha}-tocopherol/ml plasma. Final concentrations of 4, 8, and 16 µg ß-carotene were adjusted, respectively, per ml plasma. Tubes were incubated in a 37°C water bath under nitrogen, and in the dark, for 6 hours. Samples were mixed by vortexing briefly every 30 minutes.

Experiment 2 and 3.
For {alpha}-tocopherol in experiment 2, procedures were followed according to the protocol described in Experiment 1; however, final concentrations were adjusted to 50, 100, and 200 µg {alpha}-tocopherol/ml plasma.

For ß-carotene in experiment 3, the plasma concentration were adjusted as described by Gaziano et al [34]. ß-Carotene was dissolved in tetrahydrofuran (THF) and added to plasma to reach a final concentration of 200, 300 and 500 µg ß-carotene, respectively, per ml plasma.

The samples were vortexed briefly and incubated in a 37°C water bath under nitrogen and in the dark. After 30 minutes of incubation, all samples were removed and were stored overnight at 4°C in the dark.

Isolation of LDL
LDL was isolated as described by Chung et al [35]. Enriched plasma was adjusted to a density of 1.21 g/ml by adding 0.3265 g of KI per mol plasma and layered under phosphate buffered saline (0.01 M phosphate and 0.15 M NaCl) in Quick-seal centrifuge tubes (Beckman). LDL was isolated by single vertical spin density gradient ultracentrifugation at 4°C and 300,000 xg for 3 hours using a fixed-angle Beckman 70.1 T1 rotor (Beckman Instruments, Palo Alto, CA) in a Beckman L2-85 ultracentrifuge (Beckman Instruments, Palo Alto, CA). The LDL fraction was collected by inserting the needle of a syringe into the centrifuge tube directly beneath the LDL band and aspirating the band. LDL samples were stored under nitrogen at 4°C in the dark and used within a week for experiments. The LDL fraction obtained was identified by modification of the electrophoretic techniques described by Kane (1973).

Oxidation of LDL
Prior to oxidation of LDL by incubation (0 to 4 hours) with Cu2+, LDL was filtered through PD-10 columns (Pharmacia, Uppsala, Sweden) to remove the EDTA. Protein was determined using the BCA protein assay kit (Pierce, Rockford, IL) with bovine serum albumin as the standard. A solution of 1 µl of 40 mM Cu2+ was added for every 100 mg protein per ml sample, shaken to oxygenate, placed in a 37°C water bath and covered with foil to protect against photo degradation of the antioxidants.

Aliquots were taken for initial {alpha}-tocopherol and ß-carotene content, and assessment of lipid peroxidation by thiobarbituric acid reactive substances (TBARS) [36], and at regular intervals thereafter. Oxidation was arrested by pipetting samples into glass culture tubes containing 200 µM EDTA and immediately placing on ice.

LDL {alpha}-Tocopherol and ß-Carotene Content
{alpha}-Tocopherol was extracted from LDL and analyzed by using the method of Kahlon et al [37]. For ß-carotene, 1 ml of LDL was deproteinated with 1 ml ethanol containing 0.125% BHT. The ß-carotene was extracted into 2.0 ml hexane/0.125% BHT by vortexing for 3 minutes. After a 10 minute centrifugation at 1,900 xg, 1 ml of the hexane layer was removed and evaporated to dryness in a vacuum sample concentrator (Savant Instruments, Inc, Faringdale, NY). Dried samples were stored under nitrogen at -70°C until analysis. LDL ß-carotene concentrations were quantified by reverse phase HPLC with detection at 450 nm according to a modification of the method described by Ringer et al [38]. Evaporated samples were resuspended in 200 µl mobile phase and injected into a 0.46x15 cm Utrasphere 5 µm C-18 ODS reverse phase HPLC column (Beckamn Instruments, Inc., San Ramon, CA).

Analysis of Data and Statistical Methods
The length of the lag phase for TBARS was obtained by finding the point of intersection of the slopes of the propagation and lag phases and extrapolating it to the horizontal axis [22]. The lag time is the interval between 0 minutes and the point of intersection. Maximum change in TBARS was calculated by subtracting TBARS concentration (nmol/mg LDL protein) at the end of the lag phase from the TBARS concentration at the end of the propagation phase. The rate of oxidation was determined by dividing the maximum change in TBARS by the length of the propagation phase. The length of the propagation phase is determined by subtracting time of the lag phase from the time at which the propagation phase ends.

Determination of the statistical significance of antioxidant incorporation into LDL at each level of enrichment was made by Mann-Whitney nonparametric one-tail test, except for Experiment 3 in which a two sample t-test was used. Repeated measures ANOVA was used to compare entire time course curves of LDL oxidation. Post-tests between the time course curves of all pairs of supplementation levels were done using a paired T-test. Kinetics data including lag time, maximum TBARS, and oxidation rate related to baseline antioxidant concentration and percent ß-carotene related to baseline {alpha}-tocopherol concentration was analyzed using the Pearson r. Antioxidant incorporation, TBARS and LDL antioxidant concentration are expressed as the mean±SD [39]. Coefficient of determination=r2.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Incorporation of Antioxidants into Low-Density Lipoprotein
The LDL band isolated by single vertical spin density ultracentrifugation was characterized by an orange color, and was located just above the center of the ultracentrifuge tube. When subjected to polyacrilamide gel electrophoresis and compared to published photographic data [40], the band was identifiable as LDL.

In Experiment 1, supplementation of plasma with antioxidants prior to isolation of LDL resulted in significant (p<0.05) enrichment of LDL in both {alpha}-tocopherol and ß-carotene at each of the three concentrations of supplementation. The following LDL concentrations of {alpha}-tocopherol (µg/mg LDL protein) were found for each respective level of {alpha}-tocopherol (µg/ml plasma) enrichment: 5.85±0.34 for the 0 level; 7.56±0.4 for the 30 level; 10.8±0.41 for the 40 level; 14.2±0.36 for the 50 level. The following LDL concentrations of ß-carotene (µg/mg LDL protein) were found for each respective level of ß-carotene (µg/ml plasma) enrichment: 0.25±0.05 for the 0 level; 0.35±0.06 for the 4 level; 0.58±0.05 for the 8 level; 0.97±0.3 for the 16 level.

In Experiment 2, supplementation of plasma with antioxidants prior to isolation of LDL resulted in significant (p<0.05) enrichment of LDL in {alpha}-tocopherol at each of the three concentrations of supplementation. Enrichment of LDL with ß-carotene was significant between the 0 and 200 µg levels, and between the 300 and 500 µg levels. The following LDL concentrations of {alpha}-tocopherol (µg/mg LDL protein) were found for each respective level of {alpha}-tocopherol (µg/ml plasma) enrichment: 5.20±0.40 for the 0 level; 19.60±0.4.8 for the 50 level; 41.0±7.47 for the 100 level; 72.4±9.75 for the 200 level. The following LDL concentrations of ß-carotene (µg/mg LDL protein) were found for each respective level of ß-carotene (µg/ml plasma) enrichment: 0.17±0.04 for the 0 level; 3.20±1.70 for the 200 level; 4.80±1.60 for the 300 level; 10.0±2.26 for the 500 level.

In Experiment 3, supplementation of plasma with antioxidant prior to isolation of LDL resulted in significant (p<0.01) enrichment of LDL in both {alpha}-tocopherol and ß-carotene at each of two concentrations of supplementation except for the 300 µg ß-carotene supplementation which was significant at p<0.05. The following LDL concentrations of {alpha}-tocopherol (µg/mg LDL protein) were found for each respective level of {alpha}-tocopherol (µg/ml plasma) enrichment: 7.57±0.19 for the 0 level; 34.60±3.508 for the 100 level; 71.1±6.40 for the 200 level. The following LDL concentrations of ß-carotene (µg/mg LDL protein) were found for each respective level of ß-carotene (µg/ml plasma) enrichment: 0.14±0.14 for the 0 level; 3.80±0.14 for the 300 level; 8.00±0.12 for the 500 level.

Protection of LDL by Added Antioxidants
Table 1 summarizes the effect of LDL antioxidant concentration on oxidation kinetics for Experiment 1. The rate of oxidation for the unsupplemented (0 level of {alpha}-tocopherol supplementation) LDL was nearly twice as high as the rate for {alpha}-tocopherol supplemented LDL. At the 16 µg ß-carotene level, the unsupplemented {alpha}-tocopherol LDL had an oxidation rate similar to the supplemented LDL. Lag times had a linear relationship with {alpha}-tocopherol concentration for all sets of curves but the 4 µg level of ß-carotene supplementation. TBARS activity was highest for the unsupplemented LDL (0 {alpha}-tocopherol supplementation) in all sets except for the 16 µg ß-carotene level.


View this table:
[in this window]
[in a new window]
 
Table 1. Effect of LDL Antioxidant Concentration on Oxidation Kinetics: Experiment 1

 
Overall in this experiment, LDL {alpha}-tocopherol concentration had a significant linear relationship with lag time (r2=0.490; p<0.05) and a significant inverse linear relationship with rate of oxidation (r2=0.325; p<0.05) (Fig. 1a and b). Baseline ß-carotene concentration had a significant linear relationship with TBARS activity (r2=0.563; p<0.001), and a positive (Fig. 2) but nonsignificant association with length of the lag phase and rate of oxidation.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1. Relationship between {alpha}-tocopherol and a) length of lag phase (n=16, r2=0.49, p<0.01); b) rate of LDL oxidation (n=16, r2=0.325, p<0.05).

 


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2. Relationship between ß-carotene and maximum TBARS activity (n=16, r2=0.563, p<0.001).

 
At all levels of ß-carotene supplementation, there was a linear correlation between baseline LDL {alpha}-tocopherol concentration and the percentage of baseline ß-carotene remaining at 60 minutes after the start of oxidation (r2=0.563; p<0.005). No such relationship was demonstrated for initial ß-carotene concentration and percentage of ß-carotene remaining after 60 minutes of oxidation. There was, however, a striking linear relationship (r2=0.990; p<0.001) between initial ß-carotene concentration and the amount (µg/mg LDL protein) of ß-carotene which had been oxidized in 60 minutes (Fig. 3).



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3. Relationship between initial LDL ß-carotene concentration and amount of ß-carotene oxidized in 60 minutes (r2=0.990, p<0.0001).

 
Table 2 lists the approximate time of the disappearance of ß-carotene and the onset of lipid peroxidation at each level of supplementation. In all samples, the onset of lipid peroxidation preceded the complete consumption of ß-carotene. Concentration of ß-carotene at the onset of the propagation phase varied considerably among the samples, therefore there doesn’t appear to be a critical concentration of ß-carotene which, when depleted, "allows" oxidation of LDL to occur under these conditions. Data for the disappearance of {alpha}-tocopherol over time is not available.


View this table:
[in this window]
[in a new window]
 
Table 2. Onset of Lipid Peroxidation and Consumption of ß-Carotene: Experiment 1

 
Table 3 summarizes the effect of ß-carotene enrichment levels on the kinetics of LDL oxidation. There were no significant differences in kinetics parameters between the time course of the 0, 200, and 300 µg levels of ß-carotene supplementation. However, the lag phase of 500 µg supplementation level was an average of 8 minutes shorter, the rate of oxidation was approximately 63% greater than for the other three levels of ß-carotene. These data suggest that, at the highest concentration of ß-carotene (10.0±2.26 µg/mg LDL protein), there is increased oxidation occurring. Because the only difference between the samples is the concentration of ß-carotene, it appears that ß-carotene may be participating in the oxidative reaction as a prooxidant at this concentration.


View this table:
[in this window]
[in a new window]
 
Table 3. Effect of LDL Antioxidant Concentration on Oxidation Kinetics: Experiment 2

 
Kinetics data is not available for the 50, 100, and 200 µg {alpha}-tocopherol levels.

In this experiment there was an inverse relationship between baseline ß-carotene concentration and lag phase (r2=0.608), a direct correlation between TBARS activity (r2=0.828), and rate of LDL oxidation (r2=0.8940). None of these relationships were significant, however, due to the small sample size.

Table 4 summarizes the effect of LDL antioxidant concentration on oxidation kinetics for Experiment 3. No significant differences were observed among the kinetics parameters in the time course of LDL supplemented with ß-carotene. Significant differences were observed when comparing unsupplemented plasma with each concentration of {alpha}-tocopherol supplemented plasma and significant differences were observed between each concentration of {alpha}-tocopherol supplemented plasma when compared to all other concentrations. Both LDL {alpha}-tocopherol (r2=0.960) and ß-carotene (r2=0.792) concentrations had a positive association with lag times. A negative association was observed between {alpha}-tocopherol and maximum TBARS activity (r=-0.99) and {alpha}-tocopherol and rate of oxidation (r=-0.72), whereas LDL ß-carotene concentrations exhibited a positive association with TBARS activity (r=0.86) and rate of oxidation (r=0.83).


View this table:
[in this window]
[in a new window]
 
Table 4. Effect of LDL Antioxidant Concentration on Oxidation Kinetics: Experiment 3

 
Effect of Antioxidant Concentration on Kinetics of LDL Oxidation: Comparison of All Experiments
When kinetics data from all three experiments were analyzed, LDL {alpha}-tocopherol concentration had a negative, but insignificant association with maximum TBARS and rate of oxidation. Fig. 4 shows the linear relationship (r2=0.819; p<0.0001) between LDL {alpha}-tocopherol concentration and lag phase for all experiments.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4. Relationship between LDL {alpha}-tocopherol and length of lag phase for all experiments (n=19, r2=0.819, p<0.0001).

 
A significant linear association was observed between LDL ß-carotene concentration and rate of oxidation (Fig. 5a). There was a positive, but nonsignificant, relationship between lag time and ß-carotene concentration. An exponential relationship (r2=0.646) was found between LDL ß-carotene concentration and TBARS activity for all experiments (Fig. 5b).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5. Relationship between LDL ß-carotene concentration and a) rate of oxidation (n=22, r2=0.372, p<0.005); b) TBARS concentration for all experiments (n=22, r2=0.649, p<0.05).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
We designed this study to overcome the large inter-individual variation which is usually associated with the length of the lag phase by pooling plasma from a large number healthy individuals and by loading the LDL with {alpha}-tocopherol and ß-carotene. The goal was to enrich the LDL with a range of concentrations of both {alpha}-tocopherol and ß-carotene without exceeding physiological concentrations. LDL {alpha}-tocopherol and ß-carotene concentrations in vivo in supplemented individually have been reported to range from 3.4±1.3 at baseline to 15.5±3.6 µg/mg protein [41] and up to 9.1±4.47 µg mg protein [42] respectively. LDL {alpha}-tocopherol concentrations were within such reported values in Experiment 1. In Experiments 2 and 3, LDL {alpha}-tocopherol concentration exceeded physiological concentration in plasma supplemented with 100 and 200 µg {alpha}-tocopherol/ml plasma. Although the {alpha}-tocopherol concentration in these experiments did exceed physiological concentration, the effect of such concentration on LDL oxidation kinetics was worth examining.

The length of the lag phase had a strong linear correlation with LDL {alpha}-tocopherol content in these experiments. Using the slope of the relationship between LDL {alpha}-tocopherol concentration and the lag phase determined in these experiments, the results suggest that for every microgram increase of LDL {alpha}-tocopherol content, there is a corresponding increase in lag time of 1.55 minutes under these conditions.

A negative association between baseline LDL {alpha}-tocopherol concentration and the rate of oxidation was observed in these experiments. Although the relationship between {alpha}-tocopherol concentration and TBARS was not significant, the combined effects of a slight decrease in TBARS activity and a longer propagation phase resulted in the observed decreased rate of oxidation. These results suggest that increased concentration of {alpha}-tocopherol not only prolongs the time period before autocatalytic oxidation begins, but slows the autooxidative reactions once the propagation phase begins, and, ultimately, decreases the final concentration of oxidative products for up to 4 hours.

A number of studies which examined the effect of structural and compositional characteristics of LDL related to its oxidative susceptibility concluded that these characteristics determined LDL’s resistance to oxidation. By pooling a large number of individual samples that, theoretically, had a wide range of structural and compositional characteristics, it was possible to separate the proposed effect of these different characteristics from the effect of {alpha}-tocopherol and ß-carotene concentrations. It appears that LDL {alpha}-tocopherol concentration is indeed an independent variable in the determination of lag phase length.

The observations: 1) {alpha}-tocopherol concentration was related to a slowing of the rate of the lipid peroxidation in the propagation phase, and 2) a decrease in the final concentration of TBARS, can be explained in terms of the amount of peroxyl radicals scavenged by {alpha}-tocopherol. The more molecules of {alpha}-tocopherol that are present in each LDL particle, the greater the ratio of {alpha}-tocopherol to unsaturated fatty acids. An increased ratio of {alpha}-tocopherol to unsaturated fatty acids corresponds to increased peroxyl radical-scavenging, therefore, decreased production of degradative products of lipid peroxidation. This equates to increased lag time and formation rate of TBARS.

In all experiments, increased LDL concentrations of ß-carotene were correlated with rate and TBARS concentration. The high level of TBARS generated with higher concentrations of ß-carotene very likely accounts for the increase in rate of oxidation observed with the higher concentrations of ß-carotene, because the length of the lag phase was not related to ß-carotene concentration. Three observations related to ß-carotene concentration in these experiments are of particular interest. Firstly, with increasing LDL concentrations of ß-carotene there is a corresponding increase in ß-carotene oxidation, so that for every microgram increase of LDL ß-carotene, there is a loss of between 0.7 and 0.8 µg of ß-carotene under the conditions of these experiments. Secondly, there appears to be an exponential relationship between TBARS concentration and ß-carotene concentration. Thirdly, when data from all experiments is analyzed together, there is a positive association between the length of the lag phase and ß-carotene concentration. These results do not find support in published studies to date. In the only study published previous to this work in which similar conditions were used, Gaziano et al [34] found that, although there was increased oxidative susceptibility of LDL from men who had taken ß-carotene supplements, LDL loaded with ß-carotene in vitro did not display increased susceptibility to Cu2+-mediated oxidation.

Our observations do support the suggestion that the carbon-centered radical (LOO-ß-carotene radical) can, under ambient to high oxygen tension, react with oxygen to form peroxyl radicals (LOO-ß-carotene-OO · ), therefore participating in the propagating reaction [43]. The trend toward increased lag phase with increasing ß-carotene concentrations may be the initial result of ß-carotene’s radical scavenging properties. However, the initial antioxidant action is followed by an amplification of oxidative reactions with the lipid peroxyl-ß-carotene-peroxyl radical participating in the chain reaction. This explains the nearly 1 to 1 relationship between ß-carotene concentration and ß-carotene oxidation, and the exponential increase in TBARS with increasing ß-carotene concentration observed in this study.


    CONCLUSIONS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
There are limitations in extrapolating from our findings to describe what may occur in vivo. However, in this study, it was observed that increased LDL {alpha}-tocopherol concentration corresponds to an increased lag phase. This support observation from previous studies [10,13,20,23,41]. Unlike previous studies, however, the pooled samples used in these experiments allowed the generalization to be made that, under these conditions, for every microgram increase from baseline LDL {alpha}-tocopherol concentration there is a corresponding increase in lag phase of about 1.5 minutes.

It is apparent from the exponential relationship observed between LDL ß-carotene concentration and the concentration of TBARS that ß-carotene, after an initial antioxidant action, participates in the autocatalytic chain reaction of fatty acid peroxidation in the propagation phase of LDL oxidation. It appears that this occurs despite high concentration of {alpha}-tocopherol. These data suggest that increased amounts of ß-carotene in the LDL may counteract any protective effect that {alpha}-tocopherol may exert.

The results obtained in this set of experiments are not surprising considering the proposed mechanisms of antioxidant action for {alpha}-tocopherol and ß-carotene. To date, however, this study is the first to report these particular effects of {alpha}-tocopherol and ß-carotene in the kinetics of LDL oxidation using this type of system.


    ACKNOWLEDGMENTS
 
This work was supported in part by a Nevada Agricultural Station Hatch Research Grant, #1106-152-0717. Authors thank Mr. Ronald Ota for his technical assistance.


    FOOTNOTES
 
Research was done to partially fulfill thesis requirements of HT Bowen.

Received July 1, 1997. Accepted October 1, 1997.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 

  1. Brown MS, Goldstein JL: Receptor-mediated control of cholesterol metabolism. Science 191: 150–153, 1976.[Free Full Text]
  2. Goldstein JL, Brown MS: The low-density lipoprotein pathway and relation to atherosclerosis. Ann Rev Biochem 46: 897–930, 1977.[Medline]
  3. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci 76: 333–337, 1979.[Abstract/Free Full Text]
  4. Yagi K: Lipid peroxides and human diseases. Chem Phys Lipids 45: 337–351, 1987.[Medline]
  5. Schuh J, Fairclough GF, Haschemeyer RH: Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci 75: 3173–3177, 1978.[Abstract/Free Full Text]
  6. Avogaro P, Bon Bittolo G, Cazzolato G: Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8: 79–87, 1988.[Abstract/Free Full Text]
  7. Haberlan ME, Fong D, Cheng L: Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable lyperlipidemic rabbits. Science 241: 215–218, 1988.[Abstract/Free Full Text]
  8. Palinski W, Rosenfeld M, Yla-Herttuala S, Gurtner G, Socher S, Butler S, Parasarathy S, Carew TE, Steinberg D, Witztum J: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci 86: 1372–1376, 1989.[Abstract/Free Full Text]
  9. Blackman BC, White P, Tsou W, Finkel D: Peroxidation of plasma and platelet lipids in chronic cigarette smokers and insulin-dependent diabetics. Ann NY Acad Sci 435: 385–387, 1984.
  10. Esterbauer E, Dieber-Rotheneder M, Striegl G, Waeg G: Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53: 314S–321S, 1991.[Abstract/Free Full Text]
  11. Ledwozyw A, Michalak J, Steplan A, Kadziolka A: The relationship between plasma triglycerides, cholesterol, total lipid and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 155: 275–284, 1986.[Medline]
  12. Rosenfeld ME, Palinski W, Yla-Herttuala S, Butler S, Wiotztum JL: Distribution of oxidation specific lipo-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10: 336–349, 1990.[Abstract/Free Full Text]
  13. Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H: Effect of antioxidants on oxidative modification of LDL. Ann Med 23: 573–581, 1991.[Medline]
  14. Yla-Herttuala S, Palinski W, Rosenfeld ME: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086–1095, 1989.
  15. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL: Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14: 32–40, 1994.[Abstract/Free Full Text]
  16. Holvoet P, Perez G, Bernar H, Brouwers E, Vanloo B, Rosseneu M, Collen D: Stimulation with a monoclonal antibody (mAb4E4) or scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation. J Clin Invest 93: 89–98, 1994.
  17. Gey FK: On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Diet 37: 53–91, 1986.
  18. Bowen HT, Omaye ST: {alpha}-Tocopherol, ß-carotene, and oxidative modification of human low-density lipoprotein. In Baskin SJ, Salem H (eds): Lipid Peroxidation and Antioxidants. Washington, DC: Taylor and Francis, pp 113–123, 1997.
  19. Cathcart ME, Morel DW, Chisolm GM: Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukocyte Biol 38: 341–350, 1985.[Abstract]
  20. Jessup W, Rankin SM, DeWalley CV, Hoult RS, Scott J, Leake DS: Alpha-tocopherol consumption during low-density-lipoprotein oxidation. Biochem J 265: 399–405, 1990.[Medline]
  21. Dieber-Rotheneder M, Puhl H, Waeg G, Streigl G, Esterbauer H: Effect of oral supplementation with d-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32: 1325–1332, 1991.[Abstract]
  22. Jialal I, Grundy SM: Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 33: 899–906, 1992.[Abstract]
  23. Eserbauer E, Dieber-Rotheneder M, Striegl G, Waeg G: Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci Technol 91: 316–324, 1989.
  24. Frei B: Ascorbic acid protects lipid in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 54: 1113S–1118S, 1991.[Medline]
  25. Sato K, Niki E, Shimasaki H: Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys 279: 402–405, 1990.[Medline]
  26. Peto R, Doll RJ, Buckley JD, Scorn MD: Can dietary ß-carotene materially reduce human cancer rates? Nature 290: 201–208, 1981.[Medline]
  27. Gaziano JM, Manson JE, Buring JE, Hennekens CH: Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 669: 249–259, 1992.[Medline]
  28. Omaye ST, Zhang P: Phytochemical interactions: ß-carotene, tocopherol and ascorbic acid. In Bidlack WR, Omaye ST (eds): "Phytochemicals: Today’s Knowledge for Tomorrow’s Products." Lancaster, PA: Technomic Publishing Co., Inc., In press, 1998.
  29. Handelman CJ, Van Kuijk FJ, Chatterjee A, Krinsky NI: Characterization of products formed during autoxidation of ß-carotene. Free Rad Biol Med 10: 427–437, 1991.[Medline]
  30. Jialal I, Norkus EP, Cristol L, Grundy SM: Beta-carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1086: 134–138, 1991.[Medline]
  31. Omaye ST, Krinsky NI, Kagan VE, Mayne ST, Liebler DC, Bidlack WR: ß-Carotene: friend or foe? Fundam Appl Toxicol 40: 163–174, 1997.[Medline]
  32. Machlin LJ: "Vitamin E: A Comprehensive Treatise." New York NY: Marcel Decker, Inc., 1980.
  33. Olson JA, Krinsky NI: The colorful, fascinating world of the carotenoids: important physiologic modulator. FASEB J 9: 1547–1558, 1995.[Medline]
  34. Gaziano JM, Hatta A, Flynn M, Johnson EJ, Krinsky N, Ridker PM, Hennekens CH, Frei B: Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation. Atherosclerosis 112: 187–195, 1995.[Medline]
  35. Chung BH, Segrest JP, Ray MJ, Brinzell JD, Hokanson JE, Krause RM, Beaudrie K, Gone JT: Preparation of plasma lipoproteins: single vertical spin density gradient ultracentrifugation Meths Enzymology 128: 181–201, 1986.
  36. Buege JA, Aust SD: Microsomal lipid peroxidation. Meth Enzymol 52: 303–310, 1978.
  37. Kahlon TS, Chow FI, Hoefer JL, Betschart AA: Bioavailability of vitamin A and E as influenced by wheat bran and bran particle size. Cereal Chem 63: 490–493, 1986.
  38. Ringer TM, DeLoof MJ, Winterrowd GE, Francom SF, Gaylor SK, Ryan JA, Sanders ME, Hughes GS: Beta-carotene’s effects on serum lipoproteins and immunologic indices in humans. Am J Clin Nutr 53: 688–694, 1991.[Abstract/Free Full Text]
  39. Snedecor GW, Cochran WC: "Statistical Methods." Ames, IA: The Iowa State University Press, 1980.
  40. Kane JP: A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins. Anal Biochem 53: 350–364, 1973.[Medline]
  41. Jialal I, Fuller CJ, Huet BA: The effect of alpha-tocopherol supplementation on LDL oxidation: a dose-response study. Arterioscler Thromb Vasc Biol 15: 190–198, 1995.[Abstract/Free Full Text]
  42. Reaven PD, Khow A, Beltz W, Parasarathy S, Witztum JL: Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb 133: 590–600, 1993.
  43. Burton GW, Ingold KU: Beta-carotene: an unusual type of lipid antioxidant. Science 224: 569–573, 1984.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
J. A. Baron, B. F. Cole, L. Mott, R. Haile, M. Grau, T. R. Church, G. J. Beck, and E. R. Greenberg
Neoplastic and Antineoplastic Effects of {beta}-Carotene on Colorectal Adenoma Recurrence: Results of a Randomized Trial
J Natl Cancer Inst, May 21, 2003; 95(10): 717 - 722.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. A Leo and C. S Lieber
Alcohol, vitamin A, and {beta}-carotene: adverse interactions, including hepatotoxicity and carcinogenicity
Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1071 - 1085.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
A. Tappel and S. T. Omaye
Models of Antioxidant Protection Against Biological Oxidative Damage
J. Am. Coll. Nutr., October 1, 1998; 17(5): 468 - 469.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowen, H. T.
Right arrow Articles by Omaye, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowen, H. T.
Right arrow Articles by Omaye, S. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS